FRT vs MIST · rev $1.28B vs rev $797.0K
FRT (FRT) versus Milestone Pharmaceuticals Inc (MIST) — a side-by-side from cached financials, not a winner call.
FRT (FRT) common stock.
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
Latest reported FRT revenue for 2025-12-31 was $1.28B. Net income was $411.1M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. FRT currently screens at market cap $0.
Latest reported MIST revenue for 2026-06-30 was $797.0K. Net income was -$54.7M. MIST currently screens at market cap $160.6M.
FRT currently screens at market cap $0. MIST currently screens at market cap $160.6M.
Not investment advice. Open the FRT and MIST stock pages for the full models.
Not investment advice.